S, M., SŠ, G., I, Ć., & M, R. (2022). Direct oral anticoagulants (DOACs): From the laboratory point of view. Acta pharmaceutica (Zagreb, Croatia), 72(4), 459. https://doi.org/10.2478/acph-2022-0034
Chicago Style (17th ed.) CitationS, Margetić, Goreta SŠ, Ćelap I, and Razum M. "Direct Oral Anticoagulants (DOACs): From the Laboratory Point of View." Acta Pharmaceutica (Zagreb, Croatia) 72, no. 4 (2022): 459. https://doi.org/10.2478/acph-2022-0034.
MLA (9th ed.) CitationS, Margetić, et al. "Direct Oral Anticoagulants (DOACs): From the Laboratory Point of View." Acta Pharmaceutica (Zagreb, Croatia), vol. 72, no. 4, 2022, p. 459, https://doi.org/10.2478/acph-2022-0034.
Warning: These citations may not always be 100% accurate.